South Africa: Urgent Legal Battle - Activists Demand Action for 3,000 Gauteng Cancer Patients Awaiting Treatment

Cancer activists drag Gauteng Department of Health to court for failure to provide life-saving treatment.

Listen to this article 10 min Listen to this article 10 min "The unfortunate part is that cancer patients can't afford any more delays because any delay results in a death. I had a cancer recurrence because I could not get radiation treatment on time. Others don't get that opportunity to beat cancer twice -- they die. In this very month of November last year, I lost a dear friend who was in the same boat as 3,000 cancer patients awaiting radiation treatment and/or surgery."

These were the words of Lydia Staats, a two-time breast cancer survivor, speaking to Daily Maverick after a pivotal court appearance last week Thursday, 21 November 2024, in a case where SECTION27, representing the Cancer Alliance, is challenging the Gauteng Department of Health and nine others for failing to utilise the R784-million allocated to address radiation and surgical backlogs in the province.

SECTION27 is arguing four main points:

For the court to declare the Gauteng Department of Health's lack of action in using the funds set for cancer treatment for that cause unlawful and unconstitutional.Direct department to take necessary steps to ensure waiting patients get the urgent treatment they need, whether through the private...

AllAfrica publishes around 600 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.